Inaliti ye-Bezlotoxumab

-Delile

• Ngaphambi kokuthola umjovo we-bezlotoxumab,
• Umjovo we-Bezlotoxumab ungadala imiphumela emibi. Tshela udokotela wakho uma kukhona kulezi zimpawu ezinzima noma ezingapheli:
• Eminye imiphumela emibi ingaba mibi. Uma uhlangabezana nenye yalezi zimpawu, shayela udokotela wakho ngokushesha:

Umjovo we-Bezlotoxumab usetshenziselwa ukunciphisa ubungozi be- IClostridium difficile ukutheleleka (C. difficile noma i-CDI; uhlobo lwebhaktheriya olungadala uhudo olunzima noma olusongela impilo) ukuthi lungabuyi kubantu abasengozini enkulu yoku C. difficile ukutheleleka futhi asebevele bethatha umuthi wama-antibiotic ukwelapha IClostridium difficile. IBezlotoxumab isekilasini lemithi ebizwa ngama-antibody monoclonal. Isebenza ngokuzibophezela ku C. difficile ubuthi ukumisa imiphumela yawo emzimbeni.

IBezlotoxumab iza njengesisombululo (uketshezi) ukuze ifakwe ngomjovo (emthanjeni) ngaphezu kwemizuzu engama-60. I-Bezlotoxumab ilawulwa njengomthamo owodwa ngudokotela noma umhlengikazi.

Umjovo we-Bezlotoxumab awuthathi indawo yokwelashwa ngama-antibiotic C. difficile ukutheleleka; qhubeka nemithi yakho yama-antibiotic njengoba uqondiswe udokotela wakho.

Lo muthi ungabekelwa okunye ukusetshenziswa; buza udokotela wakho noma usokhemisi ukuthola eminye imininingwane.

Ngaphambi kokuthola umjovo we-bezlotoxumab,

• Tshela udokotela wakho kanye nosokhemisi uma unegciwane ku-bezlotoxumab, noma imuphi omunye umuthi, noma iziphi izithako zokufakwa kwe-bezlotoxumab. Buza usokhemisi wakho ukuthola uhlu lwezithako.
• Tshela udokotela wakho kanye nosokhemisi ukuthi imiphi eminye imishanguzo kadokotela neyokungabhalisi, amavithamini, izithasiselo zokudla okunempilo, nemikhiqizo yamakhambi oyithathayo noma ohlela ukuyithatha. Udokotela wakho angadinga ukushintsha imithamo yemithi yakho noma akuqaphele ngokucophelela ngemiphumela emibi.
• tshela udokotela wakho uma ngabe uke wahluleka yinhliziyo noma wake wahluleka.
• utshele udokotela wakho uma ukhulelwe, hlela ukukhulelwa, noma uncelisa.

Umjovo we-Bezlotoxumab ungadala imiphumela emibi. Tshela udokotela wakho uma kukhona kulezi zimpawu ezinzima noma ezingapheli:

• isicanucanu
• imfiva

Eminye imiphumela emibi ingaba mibi. Uma uhlangabezana nenye yalezi zimpawu, shayela udokotela wakho ngokushesha:

• ukuphelelwa umoya noma ukuphefumula kanzima
• ukuvuvukala kwamaqakala, izinyawo, umlenze, noma isisu

Umjovo we-Bezlotoxumab ungadala eminye imiphumela emibi. Shayela udokotela wakho uma unezinkinga ezingavamile ngenkathi uthola lo muthi.

Uma uthola imiphumela emibi kakhulu, wena noma udokotela wakho ungathumela umbiko kuhlelo lwe-Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting online (http://www.fda.gov/Safety/MedWatch) noma ngocingo ( 1-800-332-1088).

Uma kwenzeka ukweqisa ngokweqile, shayela ucingo losizo lokulawula ubuthi ku-1-800-222-1222. Imininingwane iyatholakala online ku-https: //www.poisonhelp.org/help. Uma isisulu siwile, saba nokuquleka, sinenkinga yokuphefumula, noma singakwazi ukuvuswa, shayela ngokushesha abezimo eziphuthumayo ku-911.

Gcina wonke ama-aphoyintimenti nodokotela wakho.

Buza usokhemisi wakho noma imiphi imibuzo onayo ngomjovo we-bezlotoxumab.

Kubalulekile ukuthi ugcine uhlu olubhaliwe lwayo yonke imishanguzo oyisebenzisayo kadokotela kanye nokungabhaliswanga (ngaphezulu kokuthenga), kanye nanoma yimiphi imikhiqizo efana namavithamini, amaminerali, noma ezinye izithako zokudla. Kufanele uze nalolu hlu njalo uma uvakashela udokotela noma uma ungeniswa esibhedlela. Kubaluleke kakhulu futhi nemininingwane ebalulekile ukuthi uphathe uma kwenzeka kunezimo eziphuthumayo.

• Zinplava^®